Suven Life Sciences hit the 10 per cent upper circuit today to close at Rs 15.85 after the US Food and Drug Administration cleared its Andhra Pradesh unit.
The facility at Nalgonda, second from the firm’s stable to get the US FDA nod, was classified as acceptable for the manufacture and supply of intermediates for active pharmaceutical ingredients. The stock opened at Rs 15 and made an intraday high/low of Rs 15.85/Rs 14.51.
